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Abstract 
Background: Long noncoding RNAs (lncRNAs) are a class of ubiquitous noncoding RNAs and have been found to 
act as tumor suppressors or oncogenes, which dramatically altered our understanding of cancer. Naked mole rat 
(NMR, Heterocephalus glaber) is an exceptionally long‑lived and cancer‑resistant rodent; however, whether lncRNAs 
play roles in cancer resistance in this seductive species remains unknown.
Results: In this study, we developed a pipeline and identified a total of 4422 lncRNAs across the NMR genome based 
on 12 published transcriptomes. Systematic analysis revealed that NMR lncRNAs share many common characteris‑
tics with other vertebrate species, such as tissue specificity and low expression. BLASTN against with 1057 human 
cancer‑related lncRNAs showed that only 5 NMR lncRNAs displayed homology, demonstrating the low sequence 
conservation between NMR lncRNAs and human cancer‑related lncRNAs. Further correlation analysis of lncRNAs and 
protein‑coding genes indicated that a total of 1295 lncRNAs were intensively coexpressed (r ≥ 0.9 or r ≤ −0.9, cP 
value ≤ 0.01) with potential tumor‑suppressor genes in NMR, and 194 lncRNAs exhibited strong correlation (r ≥ 0.8 or 
r ≤ −0.8, cP value ≤ 0.01) with four high‑molecular‑mass hyaluronan related genes that were previously identified to 
play key roles in cancer resistance of NMR.
Conclusion: In this study, we provide the first comprehensive genome‑wide analysis of NMR lncRNAs and their pos‑
sible associations with cancer resistance. Our results suggest that lncRNAs may have important effects on anticancer 
mechanism in NMR.
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Background
Naked mole rats (NMRs; Heterocephalus glaber) are 
small, nearly hairless, subterranean rodents that are 
renowned for their longevity and cancer resistance [1, 2]. 
In comparison with a similarly sized house mouse, the 
NMR exhibits unusual longevity, with a maximum lifes-
pan exceeding 30 years, making NMR the longest-living 
rodent [3–5]. In addition, NMRs are able to maintain 
health until almost the end of their lives and displayed 
exceptional resistance to multiple age-related diseases, 
such as cancer [6]. The high-molecular-mass hyaluro-
nan (HMM-HA) was proved to play a key role in regu-
lating the cancer resistance in NMR [7]. In the NMR 
cells, tumor resistance is mediated by signals from the 
HMM-HA triggering the induction of INK4 (inhibi-
tors of cyclin-dependent kinase 4) locus expression. The 
INK4 locus encodes a novel product named pALTINK4a/b 
which may have a crucial contribution to tumor resist-
ance and longevity of NMR [8]. A recent study suggested 
that NMR-specific alternative reading frame (ARF) and 
the disruption of oncogene embryonic cell-expressed 
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Ras (ERAS) regulate tumor resistance in NMR-induced 
pluripotent stem cells (NMR-iPSCs) [9]. However, the 
deeper mechanisms of anticancer in NMRs are not well 
understood, which pushes forward us to look for a better 
understanding of the ability of cancer resistance in NMR.
Long noncoding RNAs (lncRNAs) are operationally 
defined as RNA transcripts longer than 200  bp that do 
not appear to have coding potential [10]. Recent stud-
ies indicated that lncRNAs have become new players in 
cancer [11] and attracted plenty of attention in scientific 
community due to their altered expressions and dysregu-
lated functions as tumor suppressors or oncogenes in 
various human cancer types [12, 13]. Therefore, a prefer-
able comprehending of lncRNAs becomes important and 
essential for cancer research. With the rapid development 
of next-generation sequencing (NGS) techniques and 
in silico analysis, large sets of lncRNAs have been iden-
tified in many species; however, it has yet to be applied 
in NMR. Considering the close connections between 
lncRNAs and cancers, it becomes urgent and necessary 
to identify and feature lncRNAs in the attractive cancer-
resistant rodent, NMR.
In this study, we characterized for the first time the 
genome-wide lncRNA profiles in NMR and identified 
the association of lncRNAs with tumor-associated genes. 
Our results provide new insights into the longevity and 
cancer resistance in NMR, which is of essential signifi-
cance in enhancing our understanding of cancer and 
especially broaden our knowledge on mechanisms of 
cancer resistance.
Results
Genome‑wide identification and characterization of NMR 
lncRNAs
In order to comprehensively identify NMR lncRNAs, 12 
transcriptomes of three tissues (kidney, liver, and brain) 
from newborn, 4-year-old, 4-year-old with low-oxygen-
treated and 20-year-old NMRs were collected [3] (Addi-
tional file 1: Table S1). Raw datasets were first subjected 
to SolexaQA (-h 20, -l 30) [14] to remove low-quality and 
short reads, and 67.8 million reads were retained for fur-
ther analysis. Using a stringent filtering pipeline (Fig. 1), 
4422 potential lncRNAs yielded, consisting of 3684 long 
intergenic noncoding RNAs (lincRNAs), 733 antisense 
lncRNAs (anti-lncRNA) and 5 lncRNAs transcripted 
from intronic regions (in-lncRNA) (Table 1). The average 
length of NMR lncRNAs is 16,625 bp, of which in-lncR-
NAs have a significant shorter length (3922 bp) than anti-
lncRNA (19,668 bp) and lincRNA (16,037 bp). Compared 
with protein-coding genes (PCGs), lncRNAs exhibited 
a shorter length (Fig.  2a), less average number of exons 
per lncRNA transcript (2.51 vs. 8.05, Fig. 2b), but higher 
GC content (Fig.  2c). As expected, lncRNAs showed a 
significant lower expression level than PCGs by compar-
ing the fragments per kilobase of exon per million frag-
ments mapped (FPKM) values (Fig.  2d), which has also 
been observed in other species such as rainbow trout [15] 
and pacific oyster [16]. In conclusion, lncRNAs in NMR 
displayed higher GC content but shorter length, less exon 
numbers and lower expression level in comparison with 
PCGs (Fig. 2).  
Expression profiles of NMR lncRNAs
RNA-seq datasets from newborn, 4  year-old and 
20-year-old NMRs were obtained to characterize the 
expression pattern of the lncRNAs. More than 80% 
of lncRNAs are expressed at all ages of NMR. There 
are 45 lncRNAs, 29 lncRNAs and 31 lncRNAs specifi-
cally expressed in newborn, 4-year-old and 20-year-old 
NMRs, respectively. The age-specific expression of lncR-
NAs indicates that some lncRNAs may play roles in the 
growth and development of NMR. In addition, we found 
67 lncRNAs expressed particularly in 4-year-old NMR 
with low-oxygen treatment, suggesting them to be likely 
involved in low-oxygen metabolism (Fig. 3a, Table Addi-
tional file 2: S2).
Tissue-specific expression of lncRNAs was investi-
gated using RNA-seq datasets from NMR livers, kidneys 
and brains. Consistent with other vertebrate species [17, 
18], NMR lncRNAs displayed a significant tissue-specific 
expression pattern. 3667 lncRNAs are expressed at least 
in one tissue type, 190 are expressed merely in brains, 
226 specifically in kidneys, and 205 in livers (Fig.  3b, 
Additional file 2: Table S2).
Differential expression of lncRNAs across developmental 
tissues
We next utilized these 12 RNA-seq datasets to explore 
the expression dynamics of lncRNAs in the NMR 
genome. A total of 40 lncRNAs were found differentially 
expressed across the developmental tissues with a fold 
change >2 and false discovery rate (FDR) < 0.05 (Fig. 4, 
Additional file  3: Figure S1, Additional file  4: Table S3). 
Recent studies indicated that transcription of ncRNAs 
including some lncRNAs may act to regulate the capaci-
ties of their chromosomal neighboring PCGs, both nega-
tively and positively [19, 20]. Therefore, we selected 13 
lncRNAs whose expressions significantly varied in livers 
or brains and acquired their nearest neighboring PCGs 
for further analysis (Fig. 4). The 13 lncRNAs are likely to 
be highly expressed in either liver or brain of the new-
born (NB) NMR or in the liver of the older individuals, 
and we found that their nearest PCGs also exhibited 
metabolism-related or brain-related functions, indicat-
ing that some lncRNAs may have a functional connection 
with their neighboring PCGs.
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Conservation analysis between NMR, human and mouse 
lncRNAs
To identify homologs of the NMR lncRNAs in humans 
and mice, lncRNA sequences of two species were down-
loaded from GENCODE database. In all 27, 817 lncR-
NAs of humans (version 23) and 12,169 of mice (version 
M7) were requested. Orthologous analysis of lncRNAs 
of three species was performed using OrthoMCL with 
BLASTN program [21], which identified more than 4359 
(98%) NMR lncRNAs with no detectable homologs in 
both humans and mice lncRNA (Fig. 5a). Finally, merely 
11 orthologous groups are retained across three spe-
cies, revealing the deficiency of sequence conservation in 
lncRNAs (Additional file 5: Table S4).
LncRNAs display higher conservation in genomic 
position than sequence in diverse organisms [18, 22, 
23]. Therefore, we conducted the analysis of lncRNA 
positional conservation among three species. As a con-
sequence, 35 and 41 NMR lncRNAs show conservation 
with human and mice, respectively (Fig. 5b).
Homologous analysis of NMR lncRNA and human 
cancer‑related lncRNAs
NMR, a strictly subterranean and extraordinarily long-
lived eusocial mammal, was found resistant to both 
spontaneous cancer and experimentally induced tumori-
genesis [3, 24]. To investigate the sequence conservation 
between NMR lncRNAs and cancer-related lncRNAs, 
homologous analysis was performed. In this study, a total 
of 1057 experimentally supported lncRNAs associated 
with 86 human cancers were requested from Lnc2Cancer 
Fig. 1 Pipeline used for identifying lncRNA in naked mole rat. a Data preprocessing and transcriptome assembly. b LncRNA identification and clas‑
sifications
Table 1 High-quality lncRNAs identified in naked mole rat
a FPKM value was estimated by TopHat and Cufflinks with default parameters; 
Avg Average
Number Avg length (bp) Exon number Avg ExpLeva
Intergenic 3684 16,037 2.51 33.74
Intronic 5 3922 1.00 9.31
Antisense 733 19,668 2.55 7.50
Total 4422 16,625 2.51 29.33
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database [25], and then BLASTN [26] homology search 
with NMR lncRNAs, coverage of query and/or target 
>40% and E-value < 1e−5 were retained. As a result, only 
5 NMR lncRNAs showed homology (Table  2), indicat-
ing low sequence conservation between NMR lncRNAs 
and human cancer-related lncRNAs. BLASTN search-
ing of the 5 NMR lncRNAs that exhibited homology with 
human cancer-related lncRNAs (NMR-HCRLs) against 
to the NONCODE database [27] found highly similar 
sequences not only in human but also in mouse, rat, and 
etc. (data not shown), indicating that they might be con-
served across species.
To determine PCGs in NMR that possibly correlated 
with the 5 NMR-HCRLs, we conducted coexpression 
analysis between mRNAs expressed in four or more 
developmental tissues and the 5 NMR-HCRLs. Conse-
quently, 271 PCGs were intensively positively coexpressed 
with these 5 lncRNAs (Additional file 6: Table S5), while 
only 12 PCGs in NMR were negatively coexpressed with 
them (r ≥ 0.9 or r ≤ −0.9, cP value ≤ 0.01) (Additional 
file 6: Table S5). The 271 PCGs were further classified by 
Gene Ontology (GO) together with KEGG pathway anal-
ysis. As a result, we found a significant enrichment of 106 
GO terms and 3 KEGG pathways including Neuroactive 
Ligand Receptor Interaction (hsa04080), Maturity Onset 
Diabetes of the Young (hsa04950) and Glycosaminogly-
can Biosynthesis Heparan Sulfate (hsa00534) (P  <  0.01) 
(Additional file 7: Table S6).
Coexpression analysis of NMR lncRNAs with potential 
tumor‑suppressor genes
To further explore potential associations between NMR 
lncRNAs and cancer resistance, human tumor-sup-
pressor genes were utilized for further analysis. At the 
first step, a total of 1217 experimentally verified human 
tumor-suppressor genes were requested from TSGDB 
database [28], and then BLAST homology search with 
PCGs annotated from NMR genome [29]. Overall, we 
found that 901 PCGs (Additional file 8: Table S7) of NMR 
are homologs of human tumor-suppressor genes, which 
were considered as potential tumor-suppressor genes of 
NMR genome (PTSGs-NMR). In order to precisely ana-
lyze the correlationship between lncRNAs and cancer 
resistance, PTSGs-NMR and lncRNAs expressed in all 
Fig. 2 Comparisons between lncRNAs and protein‑coding genes 
(PCGs) in naked mole rats. a Sequence length. b Number of exon.  
c GC content. d Expression level
Fig. 3 Distribution of naked mole rat lncRNAs in different tissues at different ages and tissues. a Ages. b Tissues
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developmental tissues were reserved for next-step analy-
sis. As a result, 2091 lncRNAs and 726 PTSGs-NMR were 
retained for the ultimate coexpression analysis. Coex-
pression results show that ~61.93% (1295/2091) lncRNAs 
are intensively coexpressed with PTSGs-NMR (r  ≥  0.9 
or r ≤ 0.9, cP value ≤ 0.01). Interestingly, more than 64% 
(834/1295) lncRNAs are positively coexpressed with a 
group of PTSGs-NMR and meanwhile exhibit negative 
coexpression with some other PTSGs-NMR as well, sug-
gesting the possible role of lncRNAs in cancer resistance 
(Additional file  9: Table S8). To investigate the ratio of 
lncRNAs that coexpressed with potential tumor-suppres-
sor genes in tumor-prone animals such as rat, we down-
loaded rat lncRNA sequences from NONCODE database 
[27] and 12 RNA-seq datasets across three tissues types 
(kidney, liver and brain) at four developmental stages of 
rats [30], then performed coexpression analysis between 
potential tumor-suppressor genes of rat (PTSGs-Rat) 
and lncRNAs using the same method and standard in 
NMR. The FPKM value of rat mRNA was requested from 
Rat body map database [30]. In all, 706 PSTGs-Rat and 
16,328 lncRNAs were retained for coexpression analy-
sis. About 60.41% (9864/16,328) lncRNAs are strikingly 
coexpressed with 670 tumor PSTGs-Rat which is lower 
than that in NMR (Additional file 10: Table S9).
Fig. 4 Differential expression of lncRNAs across developmental tissues. Heatmap indicates the differential expression of 40 lncRNAs in brain, kidney 
and liver tissues of naked mole rats (left panel), and the function descriptions of 13 PCGs near lncRNAs of interest are showed (right panel)
Fig. 5 LncRNA conservation analysis among human (HUM), mouse 
(MUS) and naked mole rat (NMR). a Sequence conservation. b Posi‑
tional conservation
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Coexpression analysis of NMR lncRNAs with four 
HMM‑HA‑related genes
HMM-HA, the powerful trigger for the early contact 
inhibition (ECI) observed in NMR cells [31, 32], medi-
ates the cancer resistance in NMR [33]. A previous study 
revealed that the HA signaling triggering ECI in NMR is 
in part transmitted via the CD44 receptor which interacts 
with neurofibromin 2 (NF2) on the cytoplasmic face [33]. 
In addition, silencing of hyaluronan synthase 2 (HAS2) 
or overexpression of HA-degrading enzyme (HYAL2) in 
NMR cells led to susceptibility to malignant transforma-
tion and tumorigenesis in mice [7]. Hence, in order to 
comprehensively explore lncRNAs that related to HMM-
HA metabolism in NMR, we selected four HMM-HA-
related genes (CD44, NF2, HYAL2 and HAS2) to perform 
coexpression analysis with NMR lncRNAs that expressed 
in all developmental tissues. Consequently, ~9.27% lncR-
NAs (194/2091) are strongly coexpressed with them (105 
positively and 95 negatively, r ≥ 0.8 or r ≤ −0.8 with cP 
value ≤ 0.01) (Additional file 11: Table S10). Among the 
194 correlated lncRNAs, three lncRNAs including 2462, 
2463 and 2464 are transcripted from one gene locus, and 
coexpression analysis showed that 2462 is negatively cor-
related with HAS2 while 2464 is positively coexpressed 
with HYAL2; meanwhile, both 2463 and 2464 are nega-
tively coexpressed with NF2. Similar to 2464, another 
two lncRNAs (lncRNA 77 and 471) show the same cor-
relationship with HYAL2 and NF2 (Table  3). Interest-
ingly, we found that three lncRNAs (lncRNA 691, 852 
and 2980) are positively coexpressed with NF2 and nega-
tively coexpressed with HYAL2, displaying an opposite 
coexpression relationship compared with lncRNA 2464 
(Table  3). In summary, we discovered 3 lncRNAs that 
transcripted from one gene locus and had close connec-
tions with three of the four known HA-related genes of 
NMR. Besides, 6 lncRNAs were found strongly coex-
pressed with NF2 as well as HYAL2, negatively or posi-
tively. To explore the connection between HA synthesis 
and lncRNAs of tumor-prone rodent, we analyzed lncR-
NAs that coexpressed with four HA-related genes in the 
rat. Around 11.67% (1906/16,328) lncRNAs show strong 
coexpression (r ≥ 0.8 or r ≤ −0.8 with cP value ≤ 0.01) 
which is a little higher than NMR (~9.27%). Neverthe-
less, we did not detect any rat lncRNAs coexpressed with 
both NF2 and HYAL2 like that in NMR, but found some 
rat lncRNAs simultaneously coexpressed with NF2 and 
HAS2 (Additional file 12: Table S11). The different coex-
pression patten between lncRNAs and HA-related genes 
in NMR and rat may contribute to HA synthesis or tumo-
rigenesis. Collectively, these results suggest that lncRNAs 
might be involved in HMMA regulation.
Discussion
In this study, 4422 lncRNAs corresponding to 2946 loci 
were identified from the reported NMR RNA-seq data-
sets including three different tissues from newborn, 
young adult (4-year-old) and old adult (20-year-old) 
NMRs. Orthologous analysis by tool OrthoMCL indi-
cated that most of the NMR lncRNAs have detectable 
homology with neither human or mouse lncRNAs, dem-
onstrating that lncRNAs lack sequence conservation. 
However, five human lncRNAs which were previously 
reported to be cancer-related lncRNAs displayed high 
sequence conservation with NMR lncRNAs, especially 
the human lncRNA ENST00000493116 (also known as 
SOX2 overlapping transcript, SOX2OT). SOX2OT is a 
lncRNA that harbors in the intronic region of SOX2 gene 
which is one of the major regulators of pluripotency [34]. 
In human cancers, SOX2OT is co-upregulated with SOX2 
and OCT4 in esophageal squamous cell carcinoma [35] 
and was also suggested to play key roles in the induction 
Table 2 Five NMR lncRNAs show homology with human cancer-related lncRNAs
qcov coverage of query to target, tcov coverage of target to query, iden identity
LncRNA Human Qcov Tcov Iden Cancer name
4086 ENST00000602892 40.5 60.5 89.4 Acute megakaryoblastic leukemia
3653 ENST00000540687 27.8 63.8 83.6 Hepatocellular carcinoma
172 ENST00000605417 91.7 9.8 96.3 Lung adenocarcinoma
3712 ENST00000409139 55.8 34.9 81.9 Gastric cancer/hepatocellular carcinoma
1169 ENST00000493116 92.3 73.0 90 Hepatocellular carcinoma/lung squamous cell carcinoma
Table 3 NMR lncRNAs that  coexpressed with  both NF2 
and HYAL2
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and/or maintenance of SOX2 expression in breast can-
cer [36]. In NMR genome, SOX2OT has high sequence 
homology with lncRNA 1169 which is expressed only in 
brains and kidney with low-oxygen treatment but not in 
livers of NMR. The function of lncRNA 1169 in the NMR 
is not clear, but BLASTN searching of lncRNA 1169 as 
well as the other four NMR-HCRLs against the NON-
CODE database found BLAST hits on the queries, not 
only in human but also in mouse, rat, and etc., suggesting 
that they are possibly conserved across species. LncRNA 
evolution analysis by Hezroni et  al. [18] revealed that 
SOX2OT is a bona fide highly conserved lncRNAs which 
further strengthened our results.
LncRNA expression displays spatiotemporal and 
tissue-specific characteristics [37, 38] which were also 
observed in NMR. We found some lncRNAs were par-
ticularly expressed in newborn, 4-year-old or 20-year-
old NMR, exhibiting age-specific expression. The 
specific expression of 31 lncRNAs that merely detected 
in 20-year-old NMR implies their potential connection 
with aging or senescence due to the important roles of 
lncRNAs in senescence [39]. RNA-seq and microarray 
studies have identified altered lncRNAs during aging 
and in response to various types of senescence stimuli, 
such as ANRIL [40–42], MIR31HG [43], PANDA [44, 
45] and lincRNA-p21 [46, 47]. Hence, our analysis of 
NMR lncRNAs will provide new information for senes-
cence study.
It was reported that functions of lncRNAs can be 
inferred by coexpression analysis and their genome loca-
tions [48, 49]. In NMR genome, we performed coex-
pression analysis of lncRNAs with PTSGs-NMR and 
four HA-related genes. In spite of the unknown func-
tions of NMR lncRNAs, coexpression analysis showed 
~61.93% (1295/2091) of NMR lncRNAs were intensively 
coexpressed with PTSGs-NMR (r  ≥  0.9 or r  ≤  0.9, cP 
value  ≤  0.01). This ratio is slightly higher than that in 
rat, demonstrating the potential role of lncRNAs in can-
cer resistance of NMR. HA was verified to be involved 
in regulating anticancer mechanism in NMR, and we 
found that three lncRNAs transcripted from one gene 
locus are closely related to three of the four HA-related 
genes, especially lncRNA 2464 which coexpressed with 
both NF2 and HYAL2. As a result, a total of six lncRNAs 
that coexpressed with NF2 as well as HYAL2 were found. 
Unlike the NMR, in the rat, a tumor-prone rodent, we 
found some lncRNAs coexpressed with both NF2 and 
HAS2. HYAL2 is an enzyme responsible for regulating 
the degrading of HMM-HA which is the powerful trig-
ger for the contact inhibition [7, 49], while NF2 (merlin) 
interacts with CD44 receptor and mediates the contact 
inhibition [50]; both of them were verified to play crucial 
roles in cancer resistance of NMR. Comparing with other 
mammalian, NMR has2 protein has some unique amino 
acid changes which may be partially responsible for the 
NMR’s unusual function of HMM-HA [33]. LncRNAs 
expression in NMR and rat shows different coexpres-
sion characters with HA-related genes and highlights the 
potential function of lncRNAs in HMM-HA regulation 
and cancer resistance.
Conclusion
In summary, we first identified and featured lncRNAs 
across NMR genome and our integrated analysis of NMR 
lncRNAs suggests the high potential of these lncRNAs in 
regulating cancer resistance in the NMR, therefore pro-
viding new insight into understanding human cancer 
biology as well as promising targets of cancer treatment 
and anticancer drug development.
Methods
Data accessibility
The raw NMR and rat transcriptome datasets are avail-
able at National Center for Biotechnology Informa-
tion sra database (http://www.ncbi.nlm.nih.gov/sra/). 
The assembled genome sequences and annotation files 
of NMR were requested from GIGA database (http://
gigadb.org/dataset/100022). LncRNA sequences of 
human and mouse were downloaded from GENCODE 
database (http://www.gencodegenes.org/). LncRNA 
sequences of rat were downloaded from NONCODE 
database [27].
LncRNA identification pipeline
A stepwise filtering pipeline (Fig. 1) was used to identify 
putative lncRNAs from 12 RNA-seq datasets. (1) Low-
quality (Phred score  <  20) and short (length  <  30  bp) 
reads were trimmed using SolexaQA [14]. The trimmed 
and size selected reads were then mapped to the NMR’s 
genome using Tophat [50]. (2) Aligned reads were assem-
bled and merged by Cufflinks and Cuffmerge, and then 
noncoding transcripts for each sample were obtained 
by utilizing Cuffcompare [51]. Transcripts shorter than 
200 bp were excluded as putative long noncoding RNAs 
which were commonly defined as transcripts with length 
longer than 200 bp. (3) The tool coding potential calcu-
lator (CPC) was employed to assess the protein-coding 
potential of a transcript, and transcripts with CPC ≥ −1 
were eliminated [52]. (4) To evaluate which of the 
remaining transcripts contains a known protein-coding 
domain, transcripts are BLAST to Pfam database [53] 
and nonredundant protein database (NR) and those that 
with a Pfam or NR hit are excluded. (5) Transcripts with 
FPKM value lower than 0.3 were removed.
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OrthoMCL, BLAST and positional conservation analyses
According to method reported previously [23], here we 
adopted the OrthoMCL [21] pipeline to compare the 
sequence similarity of lncRNAs among NMR, mouse and 
human using the BLASTN program. The BLASTN hits 
with coverage ≥50% and E-value  ≤  1E−5 were retained 
and applied to assign putative orthologous groups using 
Markov Cluster (MCL) algorithm. BLASTN [26] homology 
search was conducted between NMR lncRNA and human 
cancer-related lncRNAs. LncRNAs with coverage of query 
and/or target >40% and E-value < 1e−5 were retained.
To perform positional conservation analyses, we first 
retrieved those lncRNAs pairs with E-value ≤ 1E−5 from 
BLAST results and regarded them as putative homolo-
gous sequences. We then constructed the syntenic blocks 
between NMR, mouse and human using MCScanX with 
default parameters [54]. When considering two ortholo-
gous protein-coding genes of G1 and G2 between naked 
mole rat and human, we detected lncRNAs within 815 kb 
of G1 in NMR and within 894 kb of G2 in human as pre-
viously suggested [18]. An lncRNA was considered to 
be found “upstream” of the protein-coding gene when it 
overlapped or ended 5′ end, and “downstream” when it 
overlapped or started the 3′ end of the protein-coding 
gene. Two lncRNAs of L1 and L2 from NMR and human 
were considered syntenic, if they were both upstream or 
both downstream of G1 and G2, with the same relative 
orientations. Similar standards and methods were also 
used to identify syntenic lncRNAs between naked mole 
rat and mouse.
Coexpression analysis
To investigate the possible correlationship between 
lncRNA and cancer-resistant, we performed coexpres-
sion analysis in both NMR and rat by testing FPKM val-
ues of their 12 transcriptomes, respectively. Tophat and 
cufflinks were used to obtain FPKM values of lncRNAs 
and mRNAs [51]. PCGs expressed in at least four devel-
opmental tissues were retained for coexpression analysis 
with 5 NMR-HCRLs. In coexpression analysis between 
lncRNAs and candidate tumor-suppressor mRNAs/HA-
related genes, lncRNAs and mRNAs that expressed in all 
tissues were reserved for analysis in both NMR and rat.
In this study, Pearson correlation coefficient (r) and 
correlation P value (cP value) were used to assess the 
coexpression relationship by an in-house matlab script. 
r ≥ 0.8 or r ≤ −0.8 with cP value ≤ 0.01 was considered 
as strong correlation, while r ≥ 0.9 or r ≤ −0.9 with cP 
value ≤ 0.01 was deemed as intensively correlation.
Functional enrichment analysis
To classify protein-coding genes that correlated 
with the 5 NMR-HCRLs, Gene Ontology and KEGG 
pathway enrichment analysis was performed using the 
hypergeometric distribution and Bonferroni correction 
for multiple hypotheses testing with a cutoff P value of 
0.01.
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